MSACL 2025 Industry Workshop Presentation *This Podium Presentation is occuring in the context of an Industry Workshop that starts at the time below. Its actual start time may be up to 40 minutes later, depending on order of presentation if there are multiple presentations planned by the workshop host. Workshop Host: Roche Day: Tuesday September 23 Time: 12:45* Location: Montreal 4 (Track 3)

The Future of Mass Spectrometry - Expert insight into a fully automated & integrated clinical mass spec solution.
	William Clarke, PhD, MBA, DABCC Johns Hopkins University School of Medicine
Presenter Bio: Dr. Clarke received his Ph.D. in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine, ending in 2002. In addition, he received an MBA focused on medical services management from the Carey School of Business at Johns Hopkins in 2007. Following his post-doctoral fellowship, he remained at Johns Hopkins, where he is a Professor in the Department of Pathology, as well as the director of Point-of-Care Testing, Reference Toxicology, and Phlebotomy for the hospital. He also serves as the Vice-Chair for Quality and Regulatory Affairs in the Department of Pathology. His research interests include clinical mass spectrometry, method development and evaluation for therapeutic drug monitoring, clinical toxicology, point-of-care testing, and development/validation of biomarkers for use in drug management. Dr. Clarke has published as author or co-author over 170 peer-reviewed manuscripts or book chapters, and is the Co-Editor of the textbook Contemporary Practice in Clinical Chemistry.

The symposium will highlight a major innovation in laboratory medicine while exploring the increasing use of mass spectrometry in clinical diagnostics as a complement to traditional chemistry and immunochemistry techniques.

The cobas Mass Spec solution a fully automated LC-MS/MS analyzer that integrates sample extraction and parallel testing using liquid chromatography cartridges - enabling random access testing at higher throughput compared to traditional LC-MS implementations.

This event is a valuable opportunity for laboratory professionals and clinicians to gain insights into the strengths and challenges of a fully automated LC-MS/MS analyzer.

*cobas® pro i 601 analyzer and Ionify reagents (iST1, iST2, iVD1, iISD, and iAED2 reagent packs) are available for sale in countries accepting the CE-Mark. Additional Ionify
reagents are in development. In the USA, these products are in development, not cleared or approved by FDA, and not available for sale.